Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

The impact of COVID-19 on human reproduction and directions for fertility treatment during the pandemic

  • Lee, Dayong (Department of Obstetrics and Gynecology, Kyungpook National University School of Medicine)
  • Received : 2021.03.16
  • Accepted : 2021.06.10
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly, resulting in a pandemic. The virus enters host cells through angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine subtype 2 (TMPRSS2). These enzymes are widely expressed in reproductive organs; hence, coronavirus disease 2019 (COVID-19) could also impact human reproduction. Current evidence suggests that sperm cells may provide an inadequate environment for the virus to penetrate and spread. Oocytes within antral follicles are surrounded by cumulus cells, which rarely express ACE2 and TMPRSS2. Thus, the possibility of transmission of the virus through sexual intercourse and assisted reproductive techniques seems unlikely. Early human embryos express coronavirus entry receptors and proteases, implying that human embryos are potentially vulnerable to SARS-CoV-2 in the early stages of development. Data on the expression of ACE2 and TMPRSS2 in the human endometrium are sparse. Moreover, it remains unclear whether SARS-CoV-2 directly affects the embryo and its implantation. A study of the effect of SARS-CoV-2 on pregnancy showed an increase in preterm delivery. Thus, vertical transmission of the virus from mother to fetus in the third trimester is possible, and further data on human reproduction are required to establish this possibility. Based on analyses of existing data, major organizations in this field have published guidelines on the treatment of infertility. Regarding these guidelines, despite the COVID-19 pandemic, reproductive treatment is crucial for the well-being of society and must be continued under suitable regulations and good standard laboratory practice protocols.

Keywords

References

  1. da Costa VG, Moreli ML, Saivish MV. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Arch Virol 2020;165:1517-26. https://doi.org/10.1007/s00705-020-04628-0
  2. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020;49:717-26. https://doi.org/10.1093/ije/dyaa033
  3. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2:100107. https://doi.org/10.1016/j.ajogmf.2020.100107
  4. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929-36. https://doi.org/10.1056/NEJMoa2001191
  5. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-80. https://doi.org/10.1016/j.cell.2020.02.052
  6. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 2020;581:221-4. https://doi.org/10.1038/s41586-020-2179-y
  7. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of COVID-19 in New York city. N Engl J Med 2020;382:2372-4. https://doi.org/10.1056/NEJMc2010419
  8. Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 2020;5:283. https://doi.org/10.1038/s41392-020-00426-x
  9. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020;367:1444-8. https://doi.org/10.1126/science.abb2762
  10. Shilts J, Crozier TW, Greenwood EJ, Lehner PJ, Wright GJ. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 2021;11:413. https://doi.org/10.1038/s41598-020-80464-1
  11. Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: a cross-sectional multicenter study in Wuhan, China. Clin Infect Dis 2021;72:e240-8. https://doi.org/10.1093/cid/ciaa1022
  12. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 2017;198:4046-53. https://doi.org/10.4049/jimmunol.1601896
  13. Khan N. Possible protective role of 17β-estradiol against COVID-19. J Allergy Infect Dis 2020;1:38-48.
  14. Costeira R, Lee KA, Murray B, Christiansen C, Castillo-Fernandez J, Ni Lochlainn M, et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study. PLoS One 2021;16:e0257051. https://doi.org/10.1371/journal.pone.0257051
  15. Ding T, Wang T, Zhang J, Cui P, Chen Z, Zhou S, et al. Analysis of ovarian injury associated with covid-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front Med (Lausanne) 2021;8:635255.
  16. Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril 2020;114:33-43. https://doi.org/10.1016/j.fertnstert.2020.05.001
  17. Kim J, Thomsen T, Sell N, Goldsmith AJ. Abdominal and testicular pain: an atypical presentation of COVID-19. Am J Emerg Med 2020;38:1542.
  18. Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, et al. Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study. MedRxiv 20037267 [Preprint]. 2020 [cited 2021 Nov 1]. Available from: https://doi.org/10.1101/2020.03.21.20037267.
  19. Yang M, Chen S, Huang B, Zhong JM, Su H, Chen YJ, et al. Pathological findings in the testes of COVID-19 patients: clinical implications. Eur Urol Focus 2020;6:1124-9. https://doi.org/10.1016/j.euf.2020.05.009
  20. Abdelhamid MH, Walschaerts M, Ahmad G, Mieusset R, Bujan L, Hamdi S. Mild experimental increase in testis and epididymis temperature in men: effects on sperm morphology according to spermatogenesis stages. Transl Androl Urol 2019;8:651-65. https://doi.org/10.21037/tau.2019.11.18
  21. Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res 2020;51:384-7. https://doi.org/10.1016/j.arcmed.2020.04.019
  22. Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril 2020;114:233-8. https://doi.org/10.1016/j.fertnstert.2020.05.028
  23. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open 2020;3:e208292. https://doi.org/10.1001/jamanetworkopen.2020.8292
  24. Song C, Wang Y, Li W, Hu B, Chen G, Xia P, et al. Detection of 2019 novel coronavirus in semen and testicular biopsy specimen of COVID-19 patients. MedRxiv 20042333 [Preprint]. 2020 [cited 2021 Nov 1]. Available from: https://doi.org/10.1101/2020.03.31.20042333.
  25. Fan C, Li K, Ding Y, Lu WL, Wang J. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. MedRxiv 20022418 [Preprint]. 2020 [cited 2021 Nov 1]. Available from: https://doi.org/10.1101/2020.02.12.20022418.
  26. Virant-Klun I, Strle F. Human oocytes express both ACE2 and BSG genes and corresponding proteins: is SARS-CoV-2 infection possible? Stem Cell Rev Rep 2021;17:278-84. https://doi.org/10.1007/s12015-020-10101-x
  27. Essahib W, Verheyen G, Tournaye H, Van de Velde H. SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts. J Assist Reprod Genet 2020;37:2657-60. https://doi.org/10.1007/s10815-020-01952-x
  28. Tan L, Lacko LA, Zhou T, Tomoiaga D, Hurtado R, Zhang T, et al. Preand peri-implantation Zika virus infection impairs fetal development by targeting trophectoderm cells. Nat Commun 2019;10:4155. https://doi.org/10.1038/s41467-019-12063-2
  29. Colaco S, Singh K, Zhou N, Bhide A, Singh D, Singh A, et al. Expression of SARS-CoV-2 receptor ACE2 and the spike protein processing enzymes in developing human embryos. arXiv 2020;2004.04935.
  30. Weatherbee BA, Glover DM, Zernicka-Goetz M. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester. Open Biol 2020;10:200162. https://doi.org/10.1098/rsob.200162
  31. Henarejos-Castillo I, Sebastian-Leon P, Devesa-Peiro A, Pellicer A, Diaz-Gimeno P. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle. Fertil Steril 2020;114:223-32. https://doi.org/10.1016/j.fertnstert.2020.06.026
  32. Zang R, Gomez Castro MF, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol 2020;5:eabc3582. https://doi.org/10.1126/sciimmunol.abc3582
  33. Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. Cell Rep 2020;32:108175. https://doi.org/10.1016/j.celrep.2020.108175
  34. Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020;15:e0230295. https://doi.org/10.1371/journal.pone.0230295
  35. Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K, et al. Single-cell RNA-seq Identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARSCoV-2. Front Cell Dev Biol 2020;8:783. https://doi.org/10.3389/fcell.2020.00783
  36. Bahadur G, Homburg R, Yoong W, Singh C, Bhat M, Kotabagi P, et al. Adverse outcomes in SAR-CoV-2 (COVID-19) and SARS virus related pregnancies with probable vertical transmission. JBRA Assist Reprod 2020;24:351-7.
  37. Verma S, Carter EB, Mysorekar IU. SARS-CoV2 and pregnancy: an invisible enemy? Am J Reprod Immunol 2020;84:e13308. https://doi.org/10.1111/aji.13308
  38. Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020;369:m2107.
  39. Gajbhiye RK, Modi DN, Mahale SD. Pregnancy outcomes, newborn complications and maternal-fetal transmission of SARSCoV-2 in women with COVID-19: a systematic review of 441 cases. MedRxiv 20062356 [Preprint]. 2020 [cited 2021 Nov 1]. Available from: https://doi.org/10.1101/2020.02.12.20062356.
  40. Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy: SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1635-40. https://doi.org/10.15585/mmwr.mm6944e2
  41. Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, et al. Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: what is known? Fertil Steril 2020;113:1140-9. https://doi.org/10.1016/j.fertnstert.2020.04.025
  42. Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021;224:35-53. https://doi.org/10.1016/j.ajog.2020.07.049
  43. Yang Z, Liu Y. Vertical transmission of severe acute respiratory syndrome coronavirus 2: a systematic review. Am J Perinatol 2020;37:1055-60. https://doi.org/10.1055/s-0040-1712161
  44. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020;11:3572. https://doi.org/10.1038/s41467-020-17436-6
  45. Tolu LB, Feyissa GT, Jeldu WG. Guidelines and best practice recommendations on reproductive health services provision amid COVID-19 pandemic: scoping review. BMC Public Health 2021;21:276. https://doi.org/10.1186/s12889-021-10346-2
  46. FIGO Committee Reproductive Medicine, Endocrinology and Infertility. Fertility treatment and COVID-19 - April 2020 guidance [Internet]. London: International Federation of Gynecology and Obstetrics; 2020 [cited 2021 Mar 16]. Available from: https://www.figo.org/fertility-treatment-and-covid-19-april-2020-guidance.
  47. ESHRE COVID-19 Working Group. ESHRE guidance on recommencing ART treatments [Internet]. Grimbergen: European Society of Human Reproduction and Embryology; 2020 [cited 2021 Mar 16]. Available from: https://www.eshre.eu/Home/COVID19WG.
  48. American Society for Reproductive Medicine. Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic [Internet]. Birmingham: American Society for Reproductive Medicine; 2020 [cited 2021 Mar 16]. Available from: https://www.asrm.org/news-and-publications/covid-19/statements/patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic.
  49. ARCS/BFS COVID Working Group. The Association of Reproductive and Clinical Scientists (ARCS) and British Fertility Society (BFS) U.K. best practice guidelines for reintroduction of routine fertility treatments during the COVID-19 pandemic [Internet]. Brentford: British Fertility Society; 2020 [cited 2021 Mar 16]. Available from: https://www.britishfertilitysociety.org.uk/2020/06/12/arcs-andbfs-u-k-best-practice-guidelines-for-reintroduction-of-routinefertility-treatments-during-the-covid-19-pandemic-2.
  50. Ory S, Veiga A, Horton M, Gianaroli L. Joint IFFS/ESHRE statement on COVID-19 vaccination for pregnant women and those considering pregnancy. Hum Reprod Open 2021;2021:hoab016. https://doi.org/10.1093/hropen/hoab016
  51. Wiweko B, Ho TM, Li R, Li TC, Tzeng CR, Kovacs G, et al. SARS-CoV-2 and assisted reproductive technology practice: an Asia Pacific Initiative on Reproduction (ASPIRE) position paper. Fertil Reprod 2020;2:115-43. https://doi.org/10.1142/S2661318220500188